1333 related articles for article (PubMed ID: 9804697)
1. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
2. Nanomolar inhibitors of AmpC beta-lactamase.
Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
[TBL] [Abstract][Full Text] [Related]
3. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
Powers RA; Blázquez J; Weston GS; Morosini MI; Baquero F; Shoichet BK
Protein Sci; 1999 Nov; 8(11):2330-7. PubMed ID: 10595535
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
Usher KC; Blaszczak LC; Weston GS; Shoichet BK; Remington SJ
Biochemistry; 1998 Nov; 37(46):16082-92. PubMed ID: 9819201
[TBL] [Abstract][Full Text] [Related]
5. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
[TBL] [Abstract][Full Text] [Related]
6. Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy.
Venturelli A; Tondi D; Cancian L; Morandi F; Cannazza G; Segatore B; Prati F; Amicosante G; Shoichet BK; Costi MP
J Med Chem; 2007 Nov; 50(23):5644-54. PubMed ID: 17956081
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
8. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
[TBL] [Abstract][Full Text] [Related]
9. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
Brenwald NP; Andrews J; Fraise AP
J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846
[No Abstract] [Full Text] [Related]
10. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.
Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Ado M; Tsuyoshi T; Dos Santos O; Gu Y; Sum FW; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Kumagai T; Weiss WJ; Shlaes DM; Knox JR; Mansour TS
J Med Chem; 2006 Jul; 49(15):4623-37. PubMed ID: 16854068
[TBL] [Abstract][Full Text] [Related]
13. Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone.
Sandanayaka VP; Prashad AS; Yang Y; Williamson RT; Lin YI; Mansour TS
J Med Chem; 2003 Jun; 46(13):2569-71. PubMed ID: 12801220
[TBL] [Abstract][Full Text] [Related]
14. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
[TBL] [Abstract][Full Text] [Related]
15. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
[TBL] [Abstract][Full Text] [Related]
16. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
Bethel CR; Hujer AM; Helfand MS; Bonomo RA
FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
[TBL] [Abstract][Full Text] [Related]
17. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.
Heinze-Krauss I; Angehrn P; Charnas RL; Gubernator K; Gutknecht EM; Hubschwerlen C; Kania M; Oefner C; Page MG; Sogabe S; Specklin JL; Winkler F
J Med Chem; 1998 Oct; 41(21):3961-71. PubMed ID: 9767633
[TBL] [Abstract][Full Text] [Related]
19. Disc methods for detecting AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Brenwald NP; Jevons G; Andrews J; Ang L; Fraise AP
J Antimicrob Chemother; 2005 Sep; 56(3):600-1. PubMed ID: 16087656
[No Abstract] [Full Text] [Related]
20. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
Wang X; Minasov G; Shoichet BK
Proteins; 2002 Apr; 47(1):86-96. PubMed ID: 11870868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
